RxDoctor Payments Data

Rajvinder Sidhu, MD

Gastroenterology · Marshall, MINPI 1699186908

Payments from drug & device makers

$4,085in general payments, 2019–2025

Across 237 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$471
  • Bristol Myers Squibb$369
  • Regeneron Healthcare Solutions, Inc.$308
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$302
  • QOL Medical, LLC$222
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$4,04199%
  • Education$441%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,085 in reported general payments places this provider in the 60th percentile of 497 gastroenterology providers in Michigan.

See all gastroenterology providers in Michigan

Medicare billing

Part B allowed, 2024
$169,512
Medicare patients
268
Services billed
4,819

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide18$12,348
TrulancePlecanatide12$10,889
ClenpiqSod Picosulf/Mag Ox/Citric Ac42$7,212
Dexlansoprazole DrDexlansoprazole19$4,382
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates57$3,675
SutabSod Sulf/Pot Chloride/Mag Sulf14$2,212
Mesalamine14$1,946
SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag14$1,688
Pantoprazole Sodium111$1,647
Omeprazole145$1,534
Esomeprazole Magnesium11$667
Dicyclomine Hcl23$654
Sucralfate23$633
Famotidine29$301

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$1,007$12,34818 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$302$10,88912 claims
Braintree Laboratories, Inc.Sutab, Suflave$25$3,90028 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 497 gastroenterology providers in Michigan.

Other gastroenterology in Marshall

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →